TASLY(600535) 证券之星·2025-03-28 09:18Core Viewpoint - Tianjin Tasly Pharmaceutical Group Co., Ltd. held its 7th meeting of the 9th Board of Directors, where several key resolutions were passed, including the appointment of additional directors and supervisors, and revisions to the company's articles of association [2][3][4] Group 1: Meeting Details - The meeting was held on March 28, 2025, at 3:00 PM in Tianjin, combining in-person and video attendance [2] - Out of 9 board members, 8 attended the meeting, with one member delegating voting rights due to work commitments [2] - The meeting complied with the Company Law and the company's articles of association, confirming its legality and validity [2] Group 2: Resolutions Passed - The board unanimously approved the proposal to appoint additional directors and supervisors, with 9 votes in favor and no opposition or abstentions [3] - The board also approved the hiring of senior management personnel, with the same voting outcome [3] - Revisions to the company's General Manager Work Guidelines were approved, reflecting the company's operational needs [3] Group 3: Upcoming Actions - The first temporary shareholders' meeting of 2025 will review the first, second, and fourth proposals from the board meeting [4] - The company will publish detailed announcements regarding these resolutions on the Shanghai Stock Exchange website [4]